Login / Signup

Tislelizumab-Induced Toxic Epidermal Necrolysis-Like Cutaneous Adverse Reaction: Rare Complication of Immune Checkpoint Inhibitor Therapy.

Xiaoqin YangShunming Xu
Published in: American journal of therapeutics (2024)
Keyphrases
  • high glucose
  • diabetic rats
  • emergency department
  • stem cells
  • adverse drug
  • bone marrow
  • mesenchymal stem cells
  • cell therapy
  • electron transfer
  • replacement therapy